e^+e^- COLLIDING BEAM EXPERIMENTS
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
Coincidence experiments (e, e′ X)
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity
Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1, E2b] adenoviral vectors
A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses
New petalodonts (Chondrichthyes) from the Upper Mississippian Bear Gulch Limestone (Namurian E2b) of Montana
Anti-tumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA
Liver Toxicities Typically Induced by First-Generation Adenoviral Vectors Can Be Reduced by Use of E1, E2b-Deleted Adenoviral Vectors
Physics and Experiments with Linear e+e- Colliders